A Phase II Trial of Gemcitabine Plus Capecitabine for Metastatic Renal Cell Cancer Previously Treated With Immunotherapy and Targeted Agents

Nizar M. Tannir, Peter F. Thall, Chaan S. Ng, Xuemei Wang, Leiko Wooten, Arlene Siefker-Radtke, Paul Mathew, Lance Pagliaro, Christopher Wood, Eric Jonasch

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase II Trial of Gemcitabine Plus Capecitabine for Metastatic Renal Cell Cancer Previously Treated With Immunotherapy and Targeted Agents'. Together they form a unique fingerprint.

Medicine & Life Sciences